大麻和酒精使用疾病流行趋势的分歧从2002年到2019年
Samuel F Acuff1, Justin C Strickland2
1Recovery Research Institute, Massachusetts General Hospital and Harvard Medical School, 151 Merrimac Street, Boston, MA 02114, USA.
Drug and alcohol dependence
|December 10, 2024
概括
尽管大麻使用量增加,但大麻使用障碍 (CUD) 的患病率下降,与酒精使用障碍 (AUD) 不同. 文化背景可能会影响人们对大麻危害的看法,影响CUD诊断和治疗需求.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 药物使用障碍 药物使用障碍
背景情况:
- 大麻的可用性,功效和消费量有所增加.
- 流行病学数据显示,在一些人群中,大麻使用障碍 (CUD) 的流行率正在下降.
- 了解这些趋势对于改善CUD的诊断工具至关重要.
研究的目的:
- 分析从2002年到2019年的CUD患病率的变化.
- 为了将CUD趋势与酒精使用障碍 (AUD) 趋势进行比较,使用AUD作为稳定的对照.
- 评估治疗参与度的变化以及对CUD和AUD的感知需求.
主要方法:
- 利用了国家药物使用和健康调查 (NSDUH) 的数据.
- 评估CUD和AUD症状的患病率,治疗参与度和感知需要.
- 计算了所有结果的时间趋势和年平均变化率 (AARC).
主要成果:
- 每日大麻使用量增加了94%,而日常使用者中的CUD流行率减少了47.9%.
- 每日饮酒量下降了10.86%,每日饮酒者中的AUD患病率下降了3.9%.
- 个人CUD标准的流行率显著下降,而AUD标准显示出混合的趋势. 对大麻的治疗参与和感知需要下降,但对酒精增加 (参与) 或减少 (感知需要).
结论:
- CUD和AUD标准似乎受到文化背景和对伤害的不断变化的定义的影响.
- 2002年至2019年间,对大麻的危害的文化认知发生了变化,但对酒精却没有变化.
- 这些发现表明,需要根据不断变化的社会规范重新评估CUD的诊断标准.
相关概念视频
CNS Depressants: Alcohol and Nicotine
174
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
174
Substance Use Disorders Affecting Sleep
159
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
159
Drug Concentration Versus Time Correlation
617
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
617
Prevalence and Incidence
357
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
357
Drug Dependence
979
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
979
Diagnostic and Statistical Manual of Mental Disorders (DSM)
44
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
44


